Episode
GLP-1 Coverage: Why Employers Are Dropping Access, and What Comes Next w/ Jay Bregman
- Published
- Aug 13, 2026
- Duration seconds
- 1874
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/glp-1-hub-support-community-and-weight-loss-7228656/episodes/glp-1-coverage-why-employers-are-dropping-access-and-what-comes-next-w-jay-bregman/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656/glp-1-coverage-why-employers-are-dropping-access-and-what-comes-next-w-jay-bregman.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Send us Fan Mail Losing access to a GLP-1 can happen even when treatment is working exactly as intended. A lower BMI, an insurance change, or an employer facing open-ended costs can suddenly turn a prescription into a maze of denials, prior authorizations, and unexpected expenses. In this episode, Ana Reisdorf speaks with Jay Bregman, founder and CEO of Andel, about why traditional insurance struggles to cover high-demand medications and how direct-to-employer purchasing could offer another ...